Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Racial inequity in America's ESRD program.

D N Reddan1, L A Szczech, P S Klassen

  • 1Duke Institute of Renal Outcomes Research and Health Policy, Division of Nephrology, Duke University Medical Center, Durham, North Carolina 27710, USA.

Seminars in Dialysis
|December 29, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microalbuminuria predicts overt proteinuria among patients with HIV infection.

HIV medicine·2010
Same author

Research in HIV-related renal diseases lags behind their burden to the 'positive' community.

Kidney international·2007
Same author

Cinacalcet HCI (Sensipar/Mimpara) is an effective chronic therapy for hemodialysis patients with secondary hyperparathyroidism.

Clinical nephrology·2007
Same author

Predialysis nephrologist care and access to kidney transplantation in the United States.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2007
Same author

Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients.

Kidney international·2007
Same author

Associations between CMS's Clinical Performance Measures project benchmarks, profit structure, and mortality in dialysis units.

Kidney international·2006

Racial and ethnic minorities are overrepresented in end-stage renal disease (ESRD) care. Despite disparities in treatment access, minority ESRD patients show better adjusted mortality rates, highlighting opportunities for improved outcomes.

Area of Science:

  • Nephrology
  • Health Services Research
  • Health Equity

Background:

  • Racial and ethnic minorities are disproportionately represented in end-stage renal disease (ESRD) programs.
  • The reasons for increased ESRD susceptibility in nonwhite populations are multifactorial, involving genetic, cultural, and environmental factors.
  • The ESRD program's uniform payment system offers a unique setting to study healthcare delivery variations.

Purpose of the Study:

  • To explore disparities in ESRD care delivery and outcomes for racial and ethnic minorities.
  • To investigate the reasons behind observed inequalities in treatment and transplantation referrals.
  • To identify opportunities for improving health outcomes for minority ESRD patients.

Main Methods:

  • Analysis of healthcare delivery variations within the ESRD program.

Related Experiment Videos

  • Examination of disparities in renal replacement therapy, dialysis modalities, angioaccess, and transplantation referrals.
  • Comparison of adjusted mortality rates between minority and majority populations in the ESRD program.

    • Main Results:

    • Noted disparities include overdiagnosis of hypertensive nephrosclerosis, decreased renal replacement therapy, limited home dialysis referrals, and delayed transplantation wait-listing for minorities.
    • Black patients with ESRD experience longer dialysis durations, increasing their exposure to suboptimal care processes.
    • Minority ESRD patients are less frequently referred for invasive cardiovascular procedures.
    • Despite noted inequalities, adjusted mortality rates for minority ESRD participants are lower than for the majority population.

    Conclusions:

    • Significant disparities exist in ESRD care delivery and access to treatments for racial and ethnic minorities.
    • The paradox of better adjusted mortality in minority ESRD patients despite care inequalities presents an opportunity for targeted interventions.
    • Further research is needed to understand and address the complex factors contributing to these disparities and to optimize care for all ESRD patients.